FDA approves Qfitlia to cut bleeding episodes in patients with hemophilia
The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce ...
Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?
Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response ...
Bernstein Sticks to Their Buy Rating for Sanofi (SNYNF)
Bernstein analyst Florent Cespedes maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €114.00. The ...
The Pharma Letter20h
CSL’s Hemgenix gene therapy gains German reimbursement
Australian biotech major CSL Limited (ASX: CSL) subsidiary CSL Behring today announced that it has successfully concluded ...
The Pharma Letter23h
AC Immune reports Phase II trial of ACI-7104.056
Swiss clinical-stage biotech AC Immune’s (Nasdaq: ACIU) shares closed up 5.9% at $1.90 yesterday, after it announced additional interim safety and positive immunogenicity data from the Phase II VacSYn ...
Indiatimes17h
Sanofi India Share Price
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13,532.68 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...